GSK Promises 'Greater Transparency' From Consumer Brand Reshuffle
Executive Summary
In the wake of its joint venture with Pfizer, GSK Consumer Healthcare has shaken up how it reports its sales by category to highlight the "main drivers" of performance.
You may also be interested in...
Zinc, Vitamin C Don't Reduce COVID-19 Symptoms; Impact On Shortening Colds Not Questioned
Trial with 214 adults with SARS-CoV-2 showed no significant difference among the treatment groups in number of days to symptom relief. Study didn’t measure zinc/vitamin C supplementation for shortening duration of colds.
GSK Sells Lesser Consumer Brands With Little Fanfare As Part Of Major Plan For Global Lead
Deal with Foundation Consumer Brands marks GSK’s latest sale of OTC and nutritional brands that aren’t strong enough revenue drivers to remain part of its consumer health JV with Pfizer. GSK has controlled the brands it’s divesting for less than a year.
GSK Navigates COVID-19 Opportunities And Obstacles In Q1
While some parts of the world stocked up on OTC drugs, others went into total lock down, resulting in a mixed picture for GSK's Consumer Healthcare performance in Q1.